drugset / Trial / NCT01602887
Relative Bioavailability Study
RandomizedCrossoverOpen-labelBasic science
Summary
This is a BA study comparing the bioavailability of two new capsule formulations and one solution formulation to the isethionate capsule used in phase 1 and 2 trials in healthy volunteers.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palbociclib | Small molecule | 50 mg | Oral |
| Subject | Palbociclib | Small molecule | 125 mg | Oral |
Indications
No indication recorded.